BeOne Medicines
The Director, QMS Process Owner - Global Change Control Management leads the strategy, governance, and continuous improvement of BeOne’s global GxP Change Management process across the product lifecycle. This role partners with cross-functional teams to simplify execution, integrate complex changes, and translate process data into clear decisions and measurable improvements. The position requires deep technical judgment, enterprise leadership, and the ability to build alignment across diverse stakeholders.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1-10 employees
Founded
2010
BeOne Medicines, formerly BeiGene, is committed to advancing cancer care through a science‑led, purpose‑driven model that improves treatment access for patients worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BeOne Medicines.
Associate Director, QMS Process Improvement and Analytics
BeOne Medicines
Head of QMS Transformation
UCB
Corporate Process Owner
City of Winnipeg
Senior Specialist, Global QMS
Orca Bio
Director, QMS BPO, Quality Issue Escalation, Risk & Knowledge
BeOne Medicines
Quality Management System (QMS) Lead
Tango Therapeutics